Filing Date Form TypeDescription   
   
Data pager
123
 Page 1 of 3, items 1 to 13 of 37.
2020-08-134Statement of changes in beneficial ownership of securitiesAcc-no: 0001753926-20-000248 Size: 17 KB
2019-08-143Initial statement of beneficial ownership of securitiesAcc-no: 0001179110-19-009499 Size: 5 KB
2019-08-134Statement of changes in beneficial ownership of securitiesAcc-no: 0001179110-19-009430 Size: 17 KB
2019-08-133Initial statement of beneficial ownership of securitiesAcc-no: 0001179110-19-009429 Size: 5 KB
2019-08-133Initial statement of beneficial ownership of securitiesAcc-no: 0001179110-19-009428 Size: 3 KB
2019-08-133Initial statement of beneficial ownership of securitiesAcc-no: 0001179110-19-009427 Size: 3 KB
2019-08-133Initial statement of beneficial ownership of securitiesAcc-no: 0001179110-19-009426 Size: 3 KB
2019-08-133Initial statement of beneficial ownership of securitiesAcc-no: 0001179110-19-009425 Size: 3 KB
2019-08-133Initial statement of beneficial ownership of securitiesAcc-no: 0001179110-19-009424 Size: 3 KB
2017-03-174Statement of changes in beneficial ownership of securitiesAcc-no: 0001213900-17-002555 Size: 11 KB
2017-02-074Statement of changes in beneficial ownership of securitiesAcc-no: 0001213900-17-001064 Size: 9 KB
2017-01-194Statement of changes in beneficial ownership of securitiesAcc-no: 0001213900-17-000522 Size: 4 KB
2017-01-064Statement of changes in beneficial ownership of securitiesAcc-no: 0001213900-17-000155 Size: 4 KB


RedHawk Reports 3rd Quarter Results
05/24/2021 8:15 PM

RedHawk Holdings Corp. (OTC: SNDD) ("RedHawk" or the "Company"), a diversified holding company engaged primarily in sales and distribution of medical devices, reported today a net loss from operations of $425,479 for the nine month period ended March 31, 2021 on gross revenues of $867,841. Net of distributor and introductory discounts of $177,095, net revenues for the nine month period ended March 31, 2021 were $690,746. For the trailing twelve month period ended March 31, 2021, RedHawk reported a net loss from operations of $211,986 on gross revenues of $1,831,297, and net revenues of $1,606,035.

Pharming celebrates the 10th annual "hae day :-)"
05/17/2021 5:00 AM

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) supports the 10th annual "hae-day :-)", the global awareness day for hereditary angioedema (HAE), a rare life-threatening condition.